Safety and Tolerability of PRO-143 Ophthalmic Solution in Healthy Volunteers.

Laboratorios Sophia

Status and phase: Withdrawn; Phase 1

Conditions: Conjunctivitis, Bacterial

Treatments: Drug: PRO-143 Ophthalmic Solution

Study type: Interventional

Funder types: Industry

Identifiers

NCT03698045

PRO-143

SOPH143-0212/I

Details and patient eligibility

About

Study to evaluate the safety and tolerability of PRO-143 solution ophthalmic in healthy volunteers.

Full description

A phase I, open label and unicentric clinical trial to evaluate the safety and tolerability of PRO-143 ophthalmic solution in healthy volunteers.

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy male and female.
• Age ≥ 18 years old at screening visit.

Exclusion criteria

• Any ocular or systemic condition.
• Patient with one blind eye.
• Visual acuity of 20/40 in any eye.
• Use of ocular or systemics medications.
• Contraindications or sensitivity to any component of the study treatments.
• Contact lens users.
• Ocular surgery within the past 3 months..
• Women who were not using an effective means of contraception or who were pregnant or nursing.
• Participation in any studies of investigational drugs within 90 days previous to the inclusion.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

PRO-143 Ophthalmic Solution

Experimental group

Description:

PRO-143 Ophthalmic Solution applied four times per day (c/6 hours) during 10 days.

Treatment:

Drug: PRO-143 Ophthalmic Solution